< Back to search
Filter
1

Host Dendritic Cells in Allograft Patients

for
Relapsed Non-Hodgkin's Lymphoma, Hodgkin's Disease,
Location: New York NY
Sponsor: Icahn School of Medicine at Mount Sinai

Sex: All

Age: 18 - 70

Code: NCT00935597

Phase1, Recruiting

Overnight Trials With Heat Stress in Autonomic Failure Patients With Supine Hypertension

for
Hypertension, Pure Autonomic Failure, Multiple System Atrophy,
Location: Nashville TN
Sponsor: Vanderbilt University Medical Center

Sex: All

Age: 18 - 70+

Code: NCT03042988

Recruiting

Phase II Study of Salvage Radiation Treatment After B-cell Maturation Antigen Chimeric Antigen Receptor T-cell Therapy for Relapsed Refractory Multiple Myeloma

for
Multiple Myeloma, Plasma Cell Neoplasm,
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center

Sex: All

Age: 18+

Code: NCT05336383

Phase2, Recruiting

Busulfan, Melphalan, Escalating Carfilzomib Conditioning Auto Stem Cell Transplantation for Multiple Myeloma (MM)

for
Multiple Myeloma
Location: Maywood IL
Sponsor: Loyola University

Sex: All

Age: 18+

Code: NCT03795597

Phase1, Phase2, Recruiting

Imaging Study of [89Zr]DFO-YS5 for Detecting CD46 Positive Malignancy in Multiple Myeloma

for
Multiple Myeloma, Plasma Cell Myeloma
Location: San Francisco CA
Sponsor: Robert Flavell, MD, PhD

Sex: All

Age: 18+

Code: NCT05892393

Phase1, Recruiting

Interested in new multiple sclerosis trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

A Window of Opportunity Trial to Learn if Linvoseltamab is Safe and Well Tolerated, and How Well it Works in Adult Participants With Recently Diagnosed Multiple Myeloma Who Have Not Already Received Treatment

for
Multiple Myeloma
Location: Stony Brook NY, Mineola NY, New York NY,
Sponsor: Regeneron Pharmaceuticals

Sex: All

Age: 18+

Code: NCT05828511

Phase1, Phase2, Recruiting

A Trial Comparing Single Agent Melphalan to Carmustine, Etoposide, Cytarabine, and Melphalan (BEAM) as a Preparative Regimen for Patients With Multiple Myeloma Undergoing High Dose Therapy Followed by Autologous Stem Cell Reinfusion

for
Multiple Myeloma
Location: Seattle WA
Sponsor: Swedish Medical Center

Sex: All

Age: 18 - 70

Code: NCT03570983

Phase2, Recruiting

Assessment of Allogeneic Hematopoietic Cell Transplantation in Medicare Beneficiaries With Multiple Myeloma

for
Multiple Myeloma
Location: Minneapolis MN
Sponsor: Center for International Blood and Marrow Transplant Research

Sex: All

Age: 0+

Code: NCT03127761

Recruiting

Cancer and Aging Resilience Evaluation in Older Adults With Hematologic Malignancies: The CARE-Heme Registry

for
Multiple Myeloma, Amyloidosis, Plasma Cell Leukemia
Location: Birmingham AL
Sponsor: University of Alabama at Birmingham

Sex: All

Age: 50+

Code: NCT05556928

Recruiting

Immuno-PRISM (PRecision Intervention Smoldering Myeloma)

for
High-risk Smoldering Multiple Myeloma,
Location: Boston MA, Denver CO, Portland OR
Sponsor: Irene Ghobrial, MD

Sex: All

Age: 18+

Code: NCT05469893

Phase2, Recruiting

Ability of Modulated Imaging and Laser Speckle Imaging to Determine Burn Wound Severity and Healing Potential

for
Skin Burn Multiple
Location: Orange CA
Sponsor: University of California, Irvine

Sex: All

Age: 0+

Code: NCT01166893

Recruiting

A Study to Assess BMS-986453 in Participants With Relapsed and/or Refractory Multiple Myeloma

for
Relapsed and/or Refractory Multiple Myeloma
Location: Boston MA, New Haven CT, New York NY, Tampa FL,
Sponsor: Juno Therapeutics, Inc., a Bristol-Myers Squibb Company

Sex: All

Age: 18+

Code: NCT06153251

Phase1, Recruiting

Post-Autologous Transplant Maintenance With Isatuximab and Lenalidomide in Minimal Residual Disease Positive Multiple Myeloma

for
Multiple Myeloma
Location: Chicago IL, Salt Lake City UT
Sponsor: University of Illinois at Chicago

Sex: All

Age: 18+

Code: NCT05344833

Phase2, Recruiting

Early Integration of Palliative and Supportive Care in Cellular Therapy

for
Leukemia, Lymphoma, Multiple Myeloma, Blood Cancer,
Location: Calgary
Sponsor: Alberta Health Services, Calgary

Sex: All

Age: 18+

Code: NCT05190653

Recruiting

Safety and Efficacy of CS1 CAR-T (WS-CART-CS1) in Subjects With Multiple Myeloma

for
Multiple Myeloma
Location: St Louis MO
Sponsor: Washington University School of Medicine

Sex: All

Age: 18+

Code: NCT06185751

Phase1, Recruiting

Real-time Symptom Monitoring Using ePROs to Prevent Adverse Events During Care Transitions

for
Multiple Chronic Conditions, Adverse Event
Location: Boston MA
Sponsor: Brigham and Women's Hospital

Sex: All

Age: 18+

Code: NCT05282654

Recruiting

A Study to Examine the Effects of Novel Therapy Linvoseltamab in Combination With Other Cancer Treatments for Adult Participants With Multiple Myeloma That is Resistant to Current Standard of Care Treatments

for
Multiple Myeloma
Location: Boston MA, New York NY, Chapel Hill NC,
Sponsor: Regeneron Pharmaceuticals

Sex: All

Age: 18+

Code: NCT05137054

Phase1, Recruiting

Study Using Prebiotics to Improve Gut Microbiome Diversity After Autologous Cellular Therapy

for
Multiple Myeloma, Lymphoma
Location: Omaha NE
Sponsor: University of Nebraska

Sex: All

Age: 19+

Code: NCT05135351

Recruiting

Phase I/II Open Label Study of Belumosudil Mesylate Alone, and in Combination With Dexamethasone, in Patients With Relapsed/Refractory Multiple Myeloma

for
Multiple Myeloma
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center

Sex: All

Age: 18+

Code: NCT06105554

Phase1, Phase2, Recruiting

Bortezomib, Isatuximab, Cyclophosphamide and Dexamethasone Induction in Transplant-Eligible Multiple Myeloma Patients With Renal Insufficiency

for
Multiple Myeloma
Location: Milwaukee WI
Sponsor: Medical College of Wisconsin

Sex: All

Age: 18+

Code: NCT04240054

Phase2, Recruiting